Incidence of polyomavirus-nephropathy in renal allografts: Influence of modern immunosuppressive drugs

Nephrology Dialysis Transplantation

Volumn 18, Issue 6, 2003, Pages 1190-1196

  Mengel, Michael ^a   Marwedel, Magali ^a   Radermacher, Jörg ^a   Eden, Gabriele ^a   Schwarz, Anke ^a   Haller, Hermann ^a   Kreipe, Hans ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Polyomavirus; Renal transplantation

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VIRUS PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GRAFT REJECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INTERMETHOD COMPARISON; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DISEASE; MALE; MEDICAL SCHOOL; POLYOMA VIRUS; POLYOMAVIRUS NEPHROPATHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; RISK FACTOR; SCREENING TEST; VIRUS MORPHOLOGY;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; POLYOMAVIRUS; POLYOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; RISK FACTORS; TACROLIMUS; TUMOR VIRUS INFECTIONS;

EID: 0038684561     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg072     Document Type: Article

References (23)

1. Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (B.K.) isolated from the urine after renal transplantation. Lancet 1980; 49: 219-231.
2. Padgett BL, Walker DL, Zu Rhein GM, Eckroade RJ, Dessel BH. Cultivation of papova-like virus from human brain with progressive multifocal leucencephalopathy. Lancet 1971; 1: 1257-1260
3. Shah KV. Polyomaviruses. In: Fields BN, Knipe DM, Howley PM, eds. Fields Virology. 3rd Edn., Vol. 2. Lippincott-Raven, Philadelphia: 1996: 2027-2043
4. Shah KV, Daniel RW, Warszawski RM. High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland. J Infect Dis 1973; 128: 784-787
5. Chesters PM, Heritage J, McCance DJ. Persistence of DNA sequences of BK virus and LC virus in normal human tissues and in diseased tissues. J Infect Dis 1983; 147: 676-684
6. Randhawa PS, Demetris AJ. Nephropathy due to polyomavirus type BK. N Engl J Med 2000; 342: 1361-1363
7. Stilmant MM, Freedlund MC, Schmitt GW. Cytologic evaluation of urine after kidney transplantation. Act Cytol 1987; 31: 625-630
8. Binet IF, Nickeleit V, Hirsch HH et al. Polyomavirus disease under new immunosuppressive drugs. Transplantation 1999; 67: 918-922
9. Randhawa PS, Finkelstein S, Scantlebury V et al. Human polyomavirus-associated interstitial nephritis in the allograft kidney. Transplantation 1999; 67: 103-109
10. Nickeleit V, Hirsch HH, Binet IF et al. Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. J Am Soc Nephrol 1999; 10: 1080-1089
11. Nickeleit V, Hirsch HH, Zeiler M et al. BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol Dial Transplant 2000; 15: 324-332
12. Drachenberg CB, Beskow CO, Cangro CB et al. Human polyomavirus in renal allograft biopsies: morphological findings and correlation with urine cytology. Hum Pathol 1999; 30: 970-977
13. Barri YM, Ahmad I, Ketel BL et al. Polyoma viral infection in renal transplantation: the role of immunosuppressive therapy. Clin Transplant 2001; 15: 240-246
14. Ahuja M, Cohen EP, Dayer AM et al. Polyomavirus infection after renal transplantation. Use of immunostaining as a guide to diagnosis. Transplantation 2001; 71: 896-899
15. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723
16. Colvin RB. Renal transplant pathology. In: Jennette JC, Olson JL, Schwartz MM, Silva FG, eds. Heptinstall's Pathology of the Kidney. 5rd Edn, Vol. 2. Lippincott-Raven, Philadelphia, PA: 1998: 1411-1540
17. Olyaei AJ, De Mattos AM, Bennett WM. Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies. Curr Opin Crit Care 2001; 7: 384-389
18. Haririan A, Ramos ER, Drachenberg CB, Weir MR, Klassen DK. Polyomavirus nephropathy in native kidneys of a solitary pancreas transplant recipient. Transplantation 2002; 73: 1350-1353
19. Ramos E, Drachenberg CB, Papadimitriou JC et al. Clinical course of Polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 2002; 13: 2145-2151
20. Andrei G, Snoeck R, Vandeputte M, De Clercq E. Activities of various compounds against murine and primate polyomaviruses. Antimicrob Agents Chemother 1997; 41: 587-593
21. Nickeleit V, Klimkait T, Binet IF et al. Testing for Polyomavirus Type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 2000; 342: 1309-1315
22. Hirsch HH, Knowles W, Dickmann M et al. Prospective study of Polyomavirus type BK replication and nephropathy in renal transplant recipients. N Engl J Med 2002; 347: 488-496
23. Fishman JA. BK virus nephropathy - polyomavirus adding insult to injury. N Engl J Med 2002; 347: 527-530